SHSP yields 10.38% · JNJ yields 2.13%● Live data
📍 SHSP pulled ahead of the other in Year 1
Combined, SHSP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SHSP + JNJ for your $10,000?
SharpSpring, Inc. operates as a cloud-based based marketing technology company. The company is headquartered in Gainesville Florida, Florida and currently employs 104 full-time employees. The firm offers SharpSpring, a marketing automation solution for small and medium-sized businesses and is primarily sold to marketing agencies that use the platform on behalf of their clients. The features of SharpSpring includes Web tracking, lead scoring and automated workflow that enables businesses deliver the message to the customer. SharpSpring marketing automation solution also offers customer relation management tool and call tracking functionality. Its SharpSpring Mail+ provides customers with marketing automation functionality and traditional email marketing capabilities. SharpSpring Mail+ offers tools, such as automated workflows, triggered emails and dynamic list segmentation. The Company’s subsidiaries include SharpSpring Technologies, Inc., InterInbox SA, ERNEPH 2012A (Pty) Ltd. doing business as ISMS, Perfect Audience and SMTP Holdings S.a.r.l.
Full SHSP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.